Rankings
▼
Calendar
SCYX Q4 2016 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena
SCYX
SCYNEXIS, Inc.
$37M
Q4 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$64,000
Gross Profit
$64,000
100.0% margin
Operating Income
-$6M
-8798.4% margin
Net Income
-$3M
-5389.1% margin
EPS (Diluted)
$-1.36
QoQ Revenue Growth
+0.0%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$302,000
Balance Sheet
Total Assets
$60M
Total Liabilities
$25M
Stockholders' Equity
$35M
Cash & Equivalents
$36M
← FY 2016
All Quarters
Q1 2017 →